Akero Therapeutics Inc sell dimontalban
Start price
15.09.22
/
50%
€26.40
Target price
15.09.23
€11.00
Performance (%)
-1.52%
End price
17.09.22
€26.00
Summary
This prediction ended on 17.09.22 with a price of €26.00. With a performance of -1.52%, the SELL prediction for Akero Therapeutics Inc by dimontalban was down slightly. dimontalban has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | -6.457% | -6.457% | -55.476% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to dimontalban what are the pros and cons of Akero Therapeutics Inc for the foreseeable future?
Pros
Differentiated customer and product portfolio
Sustainability is important
Stable Large shareholder and/or long term investor
Revenue growth >5% per year expected
Good rating
Standard Investments for future growth
Top 10 in its market
Known brand
Future proof or reliable business model
Cons
High valuation
High risks in the balance sheet
Increased challenges to pay loans and raise capital
Significant cyclical dependencies
Probably not worthwhile Investment
Lower EBIT Margin than peer group
EBIT decline/stagnation expected
very negative Cash Flow expected
ROE lower than 10% per year
Below average Management
Little innovation
No uniques
Growths slower than the competition
High risks for its business
Very low/no dividend yield expected
Bad culture
Comments by dimontalban for this prediction
In the thread Akero Therapeutics Inc diskutieren
Sell mit Kursziel 11,0